Cargando…
Dual domain recognition determines SARS-CoV-2 PLpro selectivity for human ISG15 and K48-linked di-ubiquitin
The Papain-like protease (PLpro) is a domain of a multi-functional, non-structural protein 3 of coronaviruses. PLpro cleaves viral polyproteins and posttranslational conjugates with polyubiquitin and protective ISG15, composed of two ubiquitin-like (UBL) domains. Across coronaviruses, PLpro showed d...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9094096/ https://www.ncbi.nlm.nih.gov/pubmed/35547846 http://dx.doi.org/10.1101/2021.09.15.460543 |
_version_ | 1784705469092200448 |
---|---|
author | Wydorski, Pawel M. Osipiuk, Jerzy Lanham, Benjamin T. Tesar, Christine Endres, Michael Engle, Elizabeth Jedrzejczak, Robert Mullapudi, Vishruth Michalska, Karolina Fidelis, Krzysztof Fushman, David Joachimiak, Andrzej Joachimiak, Lukasz A. |
author_facet | Wydorski, Pawel M. Osipiuk, Jerzy Lanham, Benjamin T. Tesar, Christine Endres, Michael Engle, Elizabeth Jedrzejczak, Robert Mullapudi, Vishruth Michalska, Karolina Fidelis, Krzysztof Fushman, David Joachimiak, Andrzej Joachimiak, Lukasz A. |
author_sort | Wydorski, Pawel M. |
collection | PubMed |
description | The Papain-like protease (PLpro) is a domain of a multi-functional, non-structural protein 3 of coronaviruses. PLpro cleaves viral polyproteins and posttranslational conjugates with polyubiquitin and protective ISG15, composed of two ubiquitin-like (UBL) domains. Across coronaviruses, PLpro showed divergent selectivity for recognition and cleavage of posttranslational conjugates despite sequence conservation. We show that SARS-CoV-2 PLpro binds human ISG15 and K48-linked di-ubiquitin (K48-Ub(2)) with nanomolar affinity and detect alternate weaker-binding modes. Crystal structures of untethered PLpro complexes with ISG15 and K48-Ub(2) combined with solution NMR and cross-linking mass spectrometry revealed how the two domains of ISG15 or K48-Ub(2) are differently utilized in interactions with PLpro. Analysis of protein interface energetics predicted differential binding stabilities of the two UBL/Ub domains that were validated experimentally. We emphasize how substrate recognition can be tuned to cleave specifically ISG15 or K48-Ub(2) modifications while retaining capacity to cleave mono-Ub conjugates. These results highlight alternative druggable surfaces that would inhibit PLpro function. |
format | Online Article Text |
id | pubmed-9094096 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Cold Spring Harbor Laboratory |
record_format | MEDLINE/PubMed |
spelling | pubmed-90940962022-05-12 Dual domain recognition determines SARS-CoV-2 PLpro selectivity for human ISG15 and K48-linked di-ubiquitin Wydorski, Pawel M. Osipiuk, Jerzy Lanham, Benjamin T. Tesar, Christine Endres, Michael Engle, Elizabeth Jedrzejczak, Robert Mullapudi, Vishruth Michalska, Karolina Fidelis, Krzysztof Fushman, David Joachimiak, Andrzej Joachimiak, Lukasz A. bioRxiv Article The Papain-like protease (PLpro) is a domain of a multi-functional, non-structural protein 3 of coronaviruses. PLpro cleaves viral polyproteins and posttranslational conjugates with polyubiquitin and protective ISG15, composed of two ubiquitin-like (UBL) domains. Across coronaviruses, PLpro showed divergent selectivity for recognition and cleavage of posttranslational conjugates despite sequence conservation. We show that SARS-CoV-2 PLpro binds human ISG15 and K48-linked di-ubiquitin (K48-Ub(2)) with nanomolar affinity and detect alternate weaker-binding modes. Crystal structures of untethered PLpro complexes with ISG15 and K48-Ub(2) combined with solution NMR and cross-linking mass spectrometry revealed how the two domains of ISG15 or K48-Ub(2) are differently utilized in interactions with PLpro. Analysis of protein interface energetics predicted differential binding stabilities of the two UBL/Ub domains that were validated experimentally. We emphasize how substrate recognition can be tuned to cleave specifically ISG15 or K48-Ub(2) modifications while retaining capacity to cleave mono-Ub conjugates. These results highlight alternative druggable surfaces that would inhibit PLpro function. Cold Spring Harbor Laboratory 2023-01-19 /pmc/articles/PMC9094096/ /pubmed/35547846 http://dx.doi.org/10.1101/2021.09.15.460543 Text en https://creativecommons.org/licenses/by-nc-nd/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which allows reusers to copy and distribute the material in any medium or format in unadapted form only, for noncommercial purposes only, and only so long as attribution is given to the creator. |
spellingShingle | Article Wydorski, Pawel M. Osipiuk, Jerzy Lanham, Benjamin T. Tesar, Christine Endres, Michael Engle, Elizabeth Jedrzejczak, Robert Mullapudi, Vishruth Michalska, Karolina Fidelis, Krzysztof Fushman, David Joachimiak, Andrzej Joachimiak, Lukasz A. Dual domain recognition determines SARS-CoV-2 PLpro selectivity for human ISG15 and K48-linked di-ubiquitin |
title | Dual domain recognition determines SARS-CoV-2 PLpro selectivity for human ISG15 and K48-linked di-ubiquitin |
title_full | Dual domain recognition determines SARS-CoV-2 PLpro selectivity for human ISG15 and K48-linked di-ubiquitin |
title_fullStr | Dual domain recognition determines SARS-CoV-2 PLpro selectivity for human ISG15 and K48-linked di-ubiquitin |
title_full_unstemmed | Dual domain recognition determines SARS-CoV-2 PLpro selectivity for human ISG15 and K48-linked di-ubiquitin |
title_short | Dual domain recognition determines SARS-CoV-2 PLpro selectivity for human ISG15 and K48-linked di-ubiquitin |
title_sort | dual domain recognition determines sars-cov-2 plpro selectivity for human isg15 and k48-linked di-ubiquitin |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9094096/ https://www.ncbi.nlm.nih.gov/pubmed/35547846 http://dx.doi.org/10.1101/2021.09.15.460543 |
work_keys_str_mv | AT wydorskipawelm dualdomainrecognitiondeterminessarscov2plproselectivityforhumanisg15andk48linkeddiubiquitin AT osipiukjerzy dualdomainrecognitiondeterminessarscov2plproselectivityforhumanisg15andk48linkeddiubiquitin AT lanhambenjamint dualdomainrecognitiondeterminessarscov2plproselectivityforhumanisg15andk48linkeddiubiquitin AT tesarchristine dualdomainrecognitiondeterminessarscov2plproselectivityforhumanisg15andk48linkeddiubiquitin AT endresmichael dualdomainrecognitiondeterminessarscov2plproselectivityforhumanisg15andk48linkeddiubiquitin AT engleelizabeth dualdomainrecognitiondeterminessarscov2plproselectivityforhumanisg15andk48linkeddiubiquitin AT jedrzejczakrobert dualdomainrecognitiondeterminessarscov2plproselectivityforhumanisg15andk48linkeddiubiquitin AT mullapudivishruth dualdomainrecognitiondeterminessarscov2plproselectivityforhumanisg15andk48linkeddiubiquitin AT michalskakarolina dualdomainrecognitiondeterminessarscov2plproselectivityforhumanisg15andk48linkeddiubiquitin AT fideliskrzysztof dualdomainrecognitiondeterminessarscov2plproselectivityforhumanisg15andk48linkeddiubiquitin AT fushmandavid dualdomainrecognitiondeterminessarscov2plproselectivityforhumanisg15andk48linkeddiubiquitin AT joachimiakandrzej dualdomainrecognitiondeterminessarscov2plproselectivityforhumanisg15andk48linkeddiubiquitin AT joachimiaklukasza dualdomainrecognitiondeterminessarscov2plproselectivityforhumanisg15andk48linkeddiubiquitin |